What is Peripheral Neuropathy?
Symptoms, Causes & Neurologist's Perspective

1. Introduction: What is the Peripheral Nervous System?

The nervous system is broadly divided into two major components: the central nervous system (CNS), comprising the brain and spinal cord, and the peripheral nervous system (PNS), which encompasses all neural tissue beyond the CNS — including sensory, motor, and autonomic nerve fibers that connect the brain and spinal cord to every organ, muscle, and region of skin in the body.

When peripheral nerves are damaged, compressed, or otherwise compromised, the result is a spectrum of conditions collectively termed peripheral neuropathy. The condition is far more prevalent than commonly appreciated: epidemiological data suggest peripheral neuropathy affects approximately 2–3% of the general population, rising to nearly 8% among adults over 55, and exceeding 50% in individuals with longstanding diabetes mellitus.

2. Anatomy of the Peripheral Nerve: Understanding Why It Matters

To understand neuropathy, one must first appreciate the functional anatomy of a peripheral nerve fiber. Each fiber is essentially a long projection (axon) of a nerve cell body, enclosed in a layered lipid membrane called the myelin sheath. Myelin serves as an electrical insulator, enabling rapid saltatory conduction of nerve impulses between nodes of Ranvier — the unmyelinated gaps between myelin segments.

Peripheral nerve fibers are classified by diameter and myelination:

• A-beta fibers (Aβ): Large, heavily myelinated — transmit touch and proprioception
• A-delta fibers (Aδ): Medium-caliber, lightly myelinated — transmit acute, well-localized sensations
• C fibers: Small, unmyelinated — transmit slow, diffuse sensations and autonomic signals

Different neuropathic processes preferentially affect different fiber types, which explains the heterogeneity of symptom presentations seen clinically.

3. Symptom Profile: How Peripheral Neuropathy Presents

The clinical presentation of peripheral neuropathy depends on which nerve fibers are affected, the distribution of involvement (focal vs. diffuse), and the mechanism of nerve injury. Symptoms can be broadly categorized as positive (due to aberrant nerve firing) or negative (due to loss of nerve function).

Temporal and Distributional Patterns

The distribution of symptoms often provides diagnostic clues. Length-dependent neuropathies — the most common pattern — begin in the longest nerve fibers first, producing the characteristic "stocking-and-glove" distribution with symptoms starting in the toes and feet before affecting the hands and lower legs. As the condition progresses, symptoms advance proximally.

Nocturnal exacerbation is a hallmark feature: many patients report that discomfort intensifies at night, attributable to the diurnal variation in cortisol (which exerts anti-inflammatory effects during the day), reduced attentional distraction, and changes in peripheral blood flow during recumbency.

4. Pathophysiology: What Goes Wrong at the Cellular Level

Several interconnected mechanisms underlie peripheral nerve dysfunction:

4.1 Oxidative Stress and Mitochondrial Dysfunction

Peripheral neurons are highly metabolically active and consequently vulnerable to oxidative damage. When mitochondrial function is impaired — whether by glucose toxicity, nutrient deficiency, or other stressors — reactive oxygen species (ROS) accumulate, damaging axonal membranes, disrupting ion channel function, and initiating inflammatory cascades.

This mechanism is particularly relevant in metabolic neuropathies: elevated glucose drives the polyol pathway (converting glucose to sorbitol via aldose reductase), depletes glutathione, and generates advanced glycation end-products (AGEs) that cross-link structural proteins and impair nerve microvasculature.

4.2 Neuroinflammation

Peripheral nerve injury activates Schwann cells, macrophages, and other resident immune cells, triggering the release of pro-inflammatory cytokines including TNF-α, IL-1β, and IL-6. Importantly, this neuroinflammatory state can become self-sustaining — even after the initial injurious stimulus resolves, chronic low-grade inflammation persists around damaged nerve fibers, perpetuating dysfunction.

Two key inflammatory signaling pathways are particularly implicated: the NF-κB pathway (central to cytokine production) and the 5-LOX pathway (responsible for leukotriene biosynthesis). Both represent rational targets for nutritional intervention.

4.3 Myelin Breakdown and Impaired Remyelination

Healthy myelin requires a continuous supply of methyl groups for phospholipid synthesis — a process critically dependent on adequate methylcobalamin (active vitamin B12). Deficiency leads to progressive demyelination, manifesting initially as slowed nerve conduction velocity and, if untreated, axonal degeneration.

5. Etiology: The Principal Causes

Peripheral neuropathy has over 100 recognized causes. The most clinically significant include:

• Diabetes mellitus (diabetic peripheral neuropathy, DPN): The most common cause worldwide, affecting up to 50% of diabetic patients. Pathogenesis involves hyperglycemia-driven oxidative stress, polyol pathway activation, and AGE accumulation.
• Nutritional deficiencies: Deficiencies of B vitamins (particularly B12, B6, B1), vitamin E, and copper can each produce distinct neuropathic syndromes. B12 deficiency is under-recognized and increasingly prevalent due to dietary changes and medication interactions (notably metformin).
• Autoimmune conditions: Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy (CIDP), vasculitic neuropathy, and paraneoplastic neuropathies.
• Toxin and medication exposure: Chemotherapy-induced peripheral neuropathy (CIPN) is a significant clinical problem; alcohol-related neuropathy represents a major preventable cause.
• Hereditary neuropathies: Charcot-Marie-Tooth disease and related hereditary motor and sensory neuropathies.
• Idiopathic (cryptogenic) neuropathy: In approximately 20–30% of cases, no definitive cause is identified despite thorough evaluation — a diagnosis of exclusion that nonetheless warrants active management.

6. Diagnosis: A Neurologist's Approach

The diagnostic evaluation of suspected peripheral neuropathy begins with a thorough history and neurological examination, followed by targeted investigations:

• Nerve conduction studies (NCS) / Electromyography (EMG): The gold standard for characterizing neuropathy type (axonal vs. demyelinating), distribution, and severity
• Laboratory evaluation: Fasting glucose, HbA1c, complete blood count, comprehensive metabolic panel, B12, folate, thyroid function, inflammatory markers, SPEP/UPEP, and etiologically directed autoimmune panels
• Skin punch biopsy: Assessment of intraepidermal nerve fiber density — particularly valuable for small-fiber neuropathy, which may be missed by NCS
• Genetic testing: When hereditary neuropathy is suspected based on family history and clinical pattern

7. Nutritional Support: A Neurologist's Perspective

While pharmacological management of neuropathic symptoms is well-established, there is growing recognition that the nutritional microenvironment of the peripheral nerve plays a crucial role in both the development and course of neuropathy. Nutritional interventions do not replace medical management but represent a rational, evidence-supported complement to standard care.

My clinical philosophy centers on targeting the two most mechanistically relevant pathways with the best-characterized nutritional agents:

7.1 Curcumin: NF-κB Modulation and Antioxidant Support

Curcumin (diferuloylmethane), the principal polyphenol of Curcuma longa, has demonstrated inhibitory activity on the NF-κB signaling cascade in multiple in vitro and in vivo models. By modulating NF-κB, curcumin reduces transcription of pro-inflammatory cytokines including TNF-α, IL-1β, and COX-2. Its lipophilicity enables penetration of the blood-brain barrier — a property rare among polyphenols and particularly relevant for neurological applications.

The principal limitation of standard curcumin preparations is poor oral bioavailability. Phospholipid complex (phytosome) technology substantially enhances curcumin absorption, making it the preferred formulation for clinical application.

7.2 Aflapin®: Selective 5-LOX Inhibition

Aflapin® is a proprietary Boswellia serrata extract standardized for high concentrations of acetyl-11-keto-β-boswellic acid (AKBA). Unlike non-selective anti-inflammatory agents, AKBA acts as a selective 5-lipoxygenase (5-LOX) inhibitor, reducing leukotriene biosynthesis without the prostaglandin pathway disruption associated with NSAIDs.

The dual-pathway approach — curcumin targeting NF-κB, Aflapin® targeting 5-LOX — provides complementary inhibition of the two principal pro-inflammatory cascades implicated in peripheral neuroinflammation. This mechanistic synergy underpins their co-formulation in NervLock Nerve Care.

8. Summary

Peripheral neuropathy is a heterogeneous condition arising from multiple etiologies but converging on common pathophysiological mechanisms: oxidative stress, mitochondrial dysfunction, neuroinflammation, and myelin compromise. While definitive treatment requires identifying and addressing the underlying cause, evidence-based nutritional support targeting the neuroinflammatory environment — particularly through dual NF-κB and 5-LOX pathway modulation — represents a rational approach to supporting peripheral neural health.

Early recognition and proactive management are key. If you experience persistent tingling, numbness, or other neuropathic symptoms, consultation with a neurologist is strongly recommended.